Murphy Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,176
Closed -$385K 206
2020
Q1
$385K Sell
2,176
-200
-8% -$37.7K 0.07% 144
2019
Q4
$454K Sell
2,376
-171
-7% -$30.8K 0.06% 153
2019
Q3
$428K Hold
2,547
0.06% 160
2019
Q2
$426K Sell
2,547
-142
-5% -$19.7K 0.06% 166
2019
Q1
$393K Sell
2,689
-635
-19% -$92.1K 0.06% 173
2018
Q4
$444K Hold
3,324
0.07% 165
2018
Q3
$633K Hold
3,324
0.09% 163
2018
Q2
$554K Sell
3,324
-68
-2% -$10.9K 0.08% 170
2018
Q1
$570K Sell
3,392
-50
-1% -$8.39K 0.08% 162
2017
Q4
$563K Sell
3,442
-439
-11% -$78.8K 0.08% 163
2017
Q3
$795K Buy
3,881
+201
+5% +$46.7K 0.11% 145
2017
Q2
$894K Sell
3,680
-300
-8% -$70.5K 0.13% 138
2017
Q1
$950K Buy
3,980
+84
+2% +$19.6K 0.14% 134
2016
Q4
$818K Sell
3,896
-229
-6% -$47.4K 0.13% 136
2016
Q3
$950K Buy
4,125
+100
+2% +$24.4K 0.15% 136
2016
Q2
$930K Sell
4,025
-129
-3% -$29.7K 0.14% 140
2016
Q1
$1.11M Sell
4,154
-345
-8% -$98.8K 0.17% 123
2015
Q4
$1.41M Sell
4,499
-750
-14% -$223K 0.21% 110
2015
Q3
$1.43M Buy
5,249
+175
+3% +$53.8K 0.24% 106
2015
Q2
$1.54M Buy
5,074
+174
+4% +$51.9K 0.23% 110
2015
Q1
$1.46M Buy
4,900
+1,475
+43% +$421K 0.22% 117
2014
Q4
$881K Sell
3,425
-120
-3% -$30K 0.13% 149
2014
Q3
$855K Buy
3,545
+1,095
+45% +$245K 0.13% 152
2014
Q2
$546K Sell
2,450
-200
-8% -$41.4K 0.09% 201
2014
Q1
$545K Hold
2,650
0.09% 205
2013
Q4
$445K Sell
2,650
-100
-4% -$15.6K 0.08% 213
2013
Q3
$396K Sell
2,750
-100
-4% -$13.3K 0.07% 214
2013
Q2
$359K Buy
+2,850
New +$323K 0.07% 215

Other funds holding AGN

Murphy Capital Management's AGN Position: Q2 2020 in Review

Murphy Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,176 shares — an estimated $385K sold.

Murphy Capital Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.54M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Murphy Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Murphy Capital Management sold 2,176 Allergan plc shares in Q2 2020, an estimated $385K.
  • Murphy Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Murphy Capital Management's Allergan plc position peaked at $1.54M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Murphy Capital Management's 13F filing for Q2 2020, filed 3 Aug 2020.